share_log
Breakings ·  Nov 11, 2024 21:02
Spruce Biosciences: Cash, Cash Equivalents Expected to Allow Co to Fund Operating Plan Through 2025 End
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment